AKT1 and lung cancer: Gills and colleagues reported decreased phosphorylation of basal and growth factor activated Akt in response to nelfinavir in lung cancer cells; however, nelfinavir-mediated reduction in Akt phosphorylation was not evident in tumor samples from xenograft models of lung cancer cells.